标题
The evolving landscape of pulmonary arterial hypertension clinical trials
作者
关键词
-
出版物
LANCET
Volume 400, Issue 10366, Pages 1884-1898
出版商
Elsevier BV
发表日期
2022-11-25
DOI
10.1016/s0140-6736(22)01601-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Trial
- (2022) Steeve Provencher et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis
- (2022) Marius M. Hoeper et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Pulmonary hypertension in Europe: a call to action
- (2022) Talha Burki Lancet Respiratory Medicine
- Assessing Daily Life Physical Activity by Actigraphy in Pulmonary Arterial Hypertension
- (2022) Luke S. Howard et al. CHEST
- Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2022) Élodie Tremblay et al. CIRCULATION
- Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership
- (2022) Jason Weatherald et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19
- (2021) NEW ENGLAND JOURNAL OF MEDICINE
- A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension
- (2021) Anna R. Hemnes et al. CHEST
- Sotatercept for the Treatment of Pulmonary Arterial Hypertension
- (2021) Marc Humbert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial
- (2021) Marius M Hoeper et al. Lancet Respiratory Medicine
- Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension
- (2021) David F. Condon et al. CHEST
- Mortality trends in pulmonary arterial hypertension in canada: a temporal analysis of survival per ESC/ERS Guideline Era
- (2021) Jason G.E. Zelt et al. EUROPEAN RESPIRATORY JOURNAL
- Temporal trends in pulmonary arterial hypertension: Results from the COMPERA registry
- (2021) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- External validation of a refined 4-strata risk assessment score from the French pulmonary hypertension Registry
- (2021) Athénaïs Boucly et al. EUROPEAN RESPIRATORY JOURNAL
- Pulmonary Arterial Hypertension
- (2021) Paul M. Hassoun NEW ENGLAND JOURNAL OF MEDICINE
- Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study
- (2021) Raymond L. Benza et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Mild parenchymal lung disease and/or low diffusion capacity impacts survival and treatment response in patients diagnosed with idiopathic pulmonary arterial hypertension
- (2020) Robert A. Lewis et al. EUROPEAN RESPIRATORY JOURNAL
- Risk assessment in pulmonary arterial hypertension: Insights from the GRIPHON study
- (2020) Olivier Sitbon et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Supervised pulmonary hypertension exercise rehabilitation (SPHERe): study protocol for a multi-centre randomised controlled trial
- (2020) Gordon McGregor et al. BMC Pulmonary Medicine
- Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure
- (2020) David M. Shavelle et al. Circulation-Heart Failure
- The AWAKE-HF Study: Sacubitril/Valsartan Impact on Daily Physical Activity and Sleep in Heart Failure
- (2020) Raj M. Khandwalla et al. American Journal of Cardiovascular Drugs
- Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials
- (2020) Jacqueline V. Scott et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Development and Validation of an Abridged Version of the REVEAL 2.0 Risk Score Calculator, REVEAL Lite 2, for use in Patients with Pulmonary Arterial Hypertension
- (2020) Raymond L. Benza et al. CHEST
- The win ratio approach for composite endpoints: practical guidance based on previous experience
- (2020) Björn Redfors et al. EUROPEAN HEART JOURNAL
- Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry
- (2020) Marius M. Hoeper et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Prediction of Health-Related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR)
- (2020) Jeff Min et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Risk Stratification in PAH: Do Not Forget the Patient Perspective!
- (2020) Marc Humbert et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- OUTSTEP‐HF: randomised controlled trial comparing short‐term effects of sacubitril/valsartan versus enalapril on daily physical activity in patients with chronic heart failure with reduced ejection fraction
- (2020) Massimo F. Piepoli et al. EUROPEAN JOURNAL OF HEART FAILURE
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- The patient experience of pulmonary hypertension: a large cross-sectional study of UK patients
- (2019) Iain Armstrong et al. BMC Pulmonary Medicine
- Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
- (2019) Marc Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- Predicting Survival in Patients with Pulmonary Arterial Hypertension
- (2019) Raymond L. Benza et al. CHEST
- Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension
- (2019) Diederik E Van der Feen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Using Bayesian adaptive designs to improve phase III trials: a respiratory care example
- (2019) Elizabeth G. Ryan et al. BMC Medical Research Methodology
- Counting Steps: A New Way to Monitor Patients with Pulmonary Arterial Hypertension
- (2019) Sameep Sehgal et al. LUNG
- Monitoring Pulmonary Arterial Hypertension Using an Implantable Hemodynamic Sensor
- (2019) Raymond L. Benza et al. CHEST
- Retrospective validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort
- (2019) James J. Anderson et al. CHEST
- Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy Results from a Phase 2 randomized, parallel group, placebo-controlled trial
- (2019) Fernando Torres et al. EUROPEAN RESPIRATORY JOURNAL
- Combination Therapy with Oral Treprostinil for Pulmonary Arterial Hypertension: A Double-Blind, Placebo-Controlled Study
- (2019) R. James White et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?
- (2018) Jason Weatherald et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Psychometric Validation of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) Questionnaire
- (2018) Kelly M. Chin et al. CHEST
- Risk assessment in pulmonary arterial hypertension
- (2018) Athénaïs Boucly et al. EUROPEAN RESPIRATORY JOURNAL
- Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality
- (2018) Vallerie V. McLaughlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome
- (2018) Alain Combes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive design clinical trials: a review of the literature and ClinicalTrials.gov
- (2018) Laura E Bothwell et al. BMJ Open
- Haemodynamics and serial risk assessment in systemic-sclerosis associated pulmonary arterial hypertension
- (2018) Jason Weatherald et al. EUROPEAN RESPIRATORY JOURNAL
- Diagnosis of pulmonary hypertension
- (2018) Adaani Frost et al. EUROPEAN RESPIRATORY JOURNAL
- The importance of patient perspectives in pulmonary hypertension
- (2018) Michael D. McGoon et al. EUROPEAN RESPIRATORY JOURNAL
- Clinical trial design and new therapies for pulmonary arterial hypertension
- (2018) Olivier Sitbon et al. EUROPEAN RESPIRATORY JOURNAL
- Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial
- (2018) Ewan C. Goligher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension
- (2017) David Kylhammar et al. EUROPEAN HEART JOURNAL
- Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
- (2017) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
- (2017) Athénaïs Boucly et al. EUROPEAN RESPIRATORY JOURNAL
- Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension
- (2017) Jason Weatherald et al. CIRCULATION
- The role of an activity monitor in the objective evaluation of patients with pulmonary hypertension
- (2016) Gulfer Okumus et al. Clinical Respiratory Journal
- Efficiencies of platform clinical trials: A vision of the future
- (2016) Benjamin R Saville et al. Clinical Trials
- The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
- (2016) Vassiliki Papadimitrakopoulou et al. JOURNAL OF CLINICAL ONCOLOGY
- Adaptive Randomization of Neratinib in Early Breast Cancer
- (2016) John W. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive Designs for Clinical Trials
- (2016) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pragmatic Trials
- (2016) Ian Ford et al. NEW ENGLAND JOURNAL OF MEDICINE
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN HEART JOURNAL
- Validation of two predictive models for survival in pulmonary arterial hypertension
- (2015) Olivier Sitbon et al. EUROPEAN RESPIRATORY JOURNAL
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN RESPIRATORY JOURNAL
- Bosentan added to sildenafil therapy in patients with pulmonary arterial hypertension
- (2015) Vallerie McLaughlin et al. EUROPEAN RESPIRATORY JOURNAL
- Selexipag for the Treatment of Pulmonary Arterial Hypertension
- (2015) Olivier Sitbon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension
- (2015) Nazzareno Galiè et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive Clinical Trial Design
- (2014) Shein-Chung Chow Annual Review of Medicine
- Are Hemodynamics Surrogate End Points in Pulmonary Arterial Hypertension?
- (2014) Corey E. Ventetuolo et al. CIRCULATION
- A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
- (2014) Rita Faria et al. PHARMACOECONOMICS
- Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
- (2014) Amelie Elsäßer et al. Trials
- Addition of Sildenafil to Long-Term Intravenous Epoprostenol Therapy in Patients with Pulmonary Arterial Hypertension
- (2013) Gérald Simonneau ANNALS OF INTERNAL MEDICINE
- Baseline and Follow-up 6-Min Walk Distance and Brain Natriuretic Peptide Predict 2-Year Mortality in Pulmonary Arterial Hypertension
- (2013) Jason S. Fritz et al. CHEST
- Imatinib Mesylate as Add-on Therapy for Pulmonary Arterial Hypertension
- (2013) Marius M. Hoeper et al. CIRCULATION
- emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension
- (2013) J. Yorke et al. EUROPEAN RESPIRATORY JOURNAL
- Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients
- (2013) Nicola Bonner et al. Health and Quality of Life Outcomes
- High-Frequency Oscillation for Acute Respiratory Distress Syndrome
- (2013) Duncan Young et al. NEW ENGLAND JOURNAL OF MEDICINE
- Macitentan and Morbidity and Mortality in Pulmonary Arterial Hypertension
- (2013) Tomás Pulido et al. NEW ENGLAND JOURNAL OF MEDICINE
- Riociguat for the Treatment of Pulmonary Arterial Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Are Routinely Collected NHS Administrative Records Suitable for Endpoint Identification in Clinical Trials? Evidence from the West of Scotland Coronary Prevention Study
- (2013) Sarah J. E. Barry et al. PLoS One
- The 6-Minute Walk Test as a Primary Endpoint in Clinical Trials for Pulmonary Hypertension⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
- (2012) Stuart Rich JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Do Changes of 6-Minute Walk Distance Predict Clinical Events in Patients With Pulmonary Arterial Hypertension?
- (2012) Gianluigi Savarese et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study
- (2012) M. F. Janssen et al. QUALITY OF LIFE RESEARCH
- Wrist Actigraphy Predicts Outcome in Patients with Pulmonary Hypertension
- (2012) Silvia Ulrich et al. RESPIRATION
- Race and Sex Differences in Response to Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension
- (2011) Nicole B. Gabler et al. CHEST
- The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension
- (2011) N. Nickel et al. EUROPEAN RESPIRATORY JOURNAL
- Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial
- (2011) William T Abraham et al. LANCET
- Assessment of Daily Life Physical Activities in Pulmonary Arterial Hypertension
- (2011) Vincent Mainguy et al. PLoS One
- Systematic review of trials using vasodilators in pulmonary arterial hypertension: Why a new approach is needed
- (2010) Alejandro Macchia et al. AMERICAN HEART JOURNAL
- Pulmonary arterial hypertension: from the kingdom of the near-dead to multiple clinical trial meta-analyses
- (2010) N. Galie et al. EUROPEAN HEART JOURNAL
- Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension
- (2010) Vallerie V. McLaughlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Tadalafil Therapy for Pulmonary Arterial Hypertension
- (2009) Nazzareno Galiè et al. CIRCULATION
- A meta-analysis of randomized controlled trials in pulmonary arterial hypertension
- (2009) N. Galie et al. EUROPEAN HEART JOURNAL
- Ambrisentan for the Treatment of Pulmonary Arterial Hypertension
- (2008) Nazzareno Galiè et al. CIRCULATION
- The impact of using different imputation methods for missing quality of life scores on the estimation of the cost-effectiveness of lung-volume-reduction surgery
- (2008) David K. Blough et al. HEALTH ECONOMICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started